About: Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.23 (-3.91%)
ACXP NASDAQ Acurx Pharmaceuticals LLC
Acurx Pharmaceuticals LLC share price
ACXP price activity
Last Price
$1.250
Change (24hr)
-0.03 USD (-2.34%)
Volume
31.77K
Volume (4w avg)
-
Open
$1.29
Day Range
$1.25 - $1.29
Previous Close
$1.28
Last Trade
13 Oct, 3:32 pm GMT+0
Delayed
13 Oct, 3:32 pm GMT+0
ACXP price performance
Delayed
13 Oct, 3:32 pm GMT+0
ACXP Market Signals